Nell Jensen, a 41-year-old from Brighton, faced lifelong obesity challenges and attempted various weight-loss methods, including the injection Wegovy, which only led to modest results. After a difficult period in her life, she sought help and was diagnosed with attention-deficit hyperactivity disorder (ADHD), a condition affecting around 3 million people in the UK and linked to obesity. Research indicates that individuals with ADHD are significantly more likely to be obese due to impulsive eating behaviors driven by low dopamine levels. After starting treatment with the ADHD medication bupropion, Nell experienced a reduction in her urge to snack impulsively, allowing her to make healthier food choices. Since beginning this treatment, she has successfully lost over three stone, reaching a healthier weight of 11 stone 11 pounds. Nell reflects on her past struggles with weight and the importance of recognizing ADHD in women, as many remain undiagnosed, which can lead to ongoing health issues.